Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. Epub 2012 Apr 30.

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.

Author information

  • 1Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany. Borwin.Bandelow@medizin.uni-goettingen.de

Erratum in

  • Int J Psychiatry Clin Pract. 2012 Sep;16(3):242.
  • Int J Psychiatry Clin Pract. 2013 Feb;17(1):76.

Abstract

OBJECTIVE:

Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners.

METHODS:

This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the field and are based on randomized controlled studies.

RESULTS:

First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy.

CONCLUSIONS:

This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.

PMID:
22540422
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk